YNVISIBLE INTERACTIVE WKN: A2JBST ISIN: CA9858441095 Kürzel: 1XNA Forum: Aktien Thema: Hauptdiskussion
0,062
EUR
-4,62 % -0,003
21:08:56 Uhr,
Lang & Schwarz
Kommentare 19.002
F
Frohlocken,
16.01.2025 21:25 Uhr
0
Aber natürlich alles mit Vorsicht zu genießen, denn Volumen ist sehr gering. Aber wenn das Volumen wieder hoch geht mit dem FDA approval dann 🍾🍾🥂
F
Frohlocken,
16.01.2025 21:23 Uhr
0
Habt ihr gesehen, dass wir auf der Heimatbörse vom Ynvisible bei CAD$0.16 heute sind? Das sind 0.11€ 👍
F
Frohlocken,
16.01.2025 21:22 Uhr
0
33ter Platz auf den heißesten Werten sind wir
F
Frohlocken,
16.01.2025 20:19 Uhr
0
Ein bisschen Spaß muss sein 👍
F
Frohlocken,
16.01.2025 20:18 Uhr
0
Wer ist noch bullish mit mir, dann bitte ein bullish einfügen 🤑
F
Frohlocken,
16.01.2025 20:18 Uhr
0
Bullish👍
F
Frohlocken,
16.01.2025 20:17 Uhr
0
Verrückt habe meine weiteren Aktien zu 0.095€ weiterhin nicht bekommen
F
l
lessismore,
16.01.2025 19:56 Uhr
1
The future of visual communication
Ynvisible's e-paper displays can seamlessly integrate into everyday life
l
lessismore,
16.01.2025 19:55 Uhr
2
- We offer the most sustainable, energy-efficient and cost-effective e-paper displays in the market
- E-paper market is rapidly growing from CAD$3.5B to > CAD$16B 2030
- We have a strong and growing global patent portfolio
- We've secured orders from customers in 4 different industries and one of our main products for medical diagnostics is under FDA review; this customer alone could reach a recurring revenue > CAD$10M/year 2026
- We are investing in our internal manufacturing and we have qualified manufacturing partners for mass production
- We are expanding our Sales & Marketing to reach new customers
- We foresee a path to CAD$40M in recurring revenue by 2026
- We are investing in Investor Relations to strengthen investor confidence
l
lessismore,
16.01.2025 19:54 Uhr
2
We offer the most sustainable, energy-efficient and cost-effective e-paper displays in the market
- E-paper market is rapidly growing from CAD$3.5B to > CAD$16B 2030
- We have a strong and growing global patent portfolio
- We've secured orders from customers in 4 different industries and one of our main products for medical diagnostics is under FDA review; this customer alone could reach a recurring revenue › CAD$10M/year 2026
- We are investing in our internal manufacturing and we have qualified manufacturing partners for mass production
- We are expanding our Sales & Marketing to reach new customers
- We foresee a path to CAD$40M in recurring revenue by 2026
l
lessismore,
16.01.2025 19:53 Uhr
2
- We offer the most sustainable, energy-efficient and cost-effective e-paper displays in the market
- E-paper market is rapidly growing from CAD$3.5B to > CAD$16B 2030
- We have a strong and growing global patent portfolio
- We've secured orders from customers in 4 different industries and one of our main products for medical diagnostics is under FDA review; this customer alone could reach a recurring revenue › CAD$10M/year 2026
- We are investing in our internal manufacturing and we have qualified manufacturing partners for mass production
- We are expanding our Sales & Marketing to reach new customers
l
lessismore,
16.01.2025 19:52 Uhr
2
We offer the most sustainable, energy-efficient and cost-effective e-paper displays in the market
- E-paper market is rapidly growing from CAD$3.5B to > CAD$16B 2030
- We have a strong and growing global patent portfolio
- We've secured orders from customers in 4 different industries and one of our main products for medical diagnostics is under FDA review; this customer alone could reach a recurring revenue › CAD$10M/year 2026
- We are investing in our internal manufacturing and we have qualified manufacturing partners for mass production
l
lessismore,
16.01.2025 19:51 Uhr
2
- We offer the most sustainable, energy-efficient and cost-effective e-paper displays in the market
- E-paper market is rapidly growing from CAD$3.5B to > CAD$16B 2030
- We have a strong and growing global patent portfolio
- We've secured orders from customers in 4 different industries and one of our main products for medical diagnostics is under FDA review; this customer alone could reach a recurring revenue › CAD$10M/year 2026
F
Frohlocken,
16.01.2025 19:05 Uhr
0
Nur mal ein Test
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Security der nächsten Generation | +9,28 % | |
| 2 | Diginex | -2,31 % | |
| 3 | RHEINMETALL Hauptdiskussion | -2,88 % | |
| 4 | Beyond Meat Hauptdiskussion | -1,29 % | |
| 5 | PLUG POWER Hauptdiskussion | +14,76 % | |
| 6 | für alle, die es ehrlich meinen beim Traden. | ||
| 7 | DPCM Capital Hauptdiskussion | +7,63 % | |
| 8 | Hims & Hers Health Registered (A) Hauptdiskussion | +4,87 % | |
| 9 | Metaplanet | +1,09 % | |
| 10 | Dax Prognose | -0,53 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | Security der nächsten Generation | +9,28 % | |
| 2 | Diginex | -2,31 % | |
| 3 | RHEINMETALL Hauptdiskussion | -2,88 % | |
| 4 | Beyond Meat Hauptdiskussion | -1,29 % | |
| 5 | PLUG POWER Hauptdiskussion | +14,76 % | |
| 6 | DPCM Capital Hauptdiskussion | +7,63 % | |
| 7 | Hims & Hers Health Registered (A) Hauptdiskussion | +4,87 % | |
| 8 | Metaplanet | +1,09 % | |
| 9 | SERVICENOW Hauptdiskussion | -0,46 % | |
| 10 | ATOS Hauptdiskussion | -3,58 % | Alle Diskussionen |